Angiotensin converting enzyme (ACE) activity levels in insulin-independentdiabetes mellitus and effect of ACE levels on diabetic patients with nephropathy
B. Ustundag et al., Angiotensin converting enzyme (ACE) activity levels in insulin-independentdiabetes mellitus and effect of ACE levels on diabetic patients with nephropathy, CELL BIOC F, 18(1), 2000, pp. 23-28
Involvement of complications is considered to be one of the major factors i
n the prognosis of diabetes mellitus (DM). Recent studies indicate that mos
t diabetic complications such as nephropathy and hypertension are vascular-
originated, Renin-angiotensin involvement, especially changes in ACE activi
ty level, is considered to be a key factor since ACE converts angiotensin I
to angiotensin II which is a potent vasoconstrictor and plays a vital role
in the regulation of blood pressure. Our present study focused on ACE acti
vity levels along with blood glucose and HbA(1c) levels in diabetic patient
s with (n = 18) or without (ii = 25) nephropathy as compared to control sub
jects (n = 25), Blood glucose levels were significantly higher in both diab
etic groups compared to controls (p < 0.001). On the other hand. compared t
o controls, blood HbA(1c) levels were slightly higher in DM patients withou
t complications whereas they were significantly increased in nephropatic DM
patients (p < 0.001). There was a very strong increase (p < 0.001) at the
level of ACE activity in both of the diabetic groups (with nephropathy: 47.
11 +/- 3.70 U l(-1); without complications: 43.72 +/- 2.93 U l(-1): control
s: 25.15 +/- 2.30 U l(-1)). ACE activity levels were also significantly hig
her in diabetic patients with nephropathy than in type II DM patients witho
ut complication (p < 0.01). Our results demonstrate that ACE activity level
s are increased in diabetic patients. Additional significant increase in AC
E activity levels in diabetic patients with complications such as nephropat
hy supports the hypothesis that ACE activity has an essential role in the d
evelopment of complications in diabetes, Copyright (C) 2000 John Wiley &: S
ons, Ltd.